Summary

Clean beauty is not a legally defined cosmetics category with a globally unified definition. Claims such as “natural origin,” “free from specific ingredients,” “no added fragrance,” “hypoallergenic,” or “biodegradable” still need to be supported by raw material composition, actual use concentrations, finished-product verification, and traceable documentation.

Raw material suppliers can substantiate ingredient identity, compositional ranges, concentrations of specific substances, test results, and document versions. However, they cannot independently demonstrate that a complete finished product is safe, complies with a particular clean beauty standard, or is suitable for absolute claims. An effective review needs to distinguish among regulatory requirements, retailer Clean Lists, internal brand standards, and voluntary certifications, while clarifying what “not added,” “not detected,” and “free from” can each substantiate.

Quick Answer

The core of clean beauty claim substantiation is not whether an ingredient sounds natural or mild, but whether a specific statement can be supported by a complete and traceable chain of evidence:

Claim wording → Raw material identity and composition → Formulation use concentration → Finished-product verification → Label wording → Document version and change management

A supplier declaration is only one part of the evidence chain. Final labeling and market claims still need to be assessed based on the complete formulation, product type, actual conditions of use, and target-market requirements.

What Is at the Center of the Clean Beauty Debate?

Clean beauty commonly reflects consumer expectations regarding ingredient transparency, raw material origin, environmental impact, and product mildness. Different brands, retail channels, and certification bodies may also establish their own restricted-substance lists, admission rules, or ingredient standards.

The controversy largely results from a common misunderstanding: treating brand standards, retailer rules, natural origin, or voluntary certification as equivalent to regulatory compliance and product safety.

The same ingredient may comply with one brand’s internal standard but fail to meet another retailer’s Clean List. It may also satisfy the requirements of a natural-origin certification while still requiring a prohibited- and restricted-substance review, ingredient-label assessment, and finished-product safety evaluation for the target market.

Regulations, Clean Lists, and Brand Standards Are Not the Same Set of Requirements

Passing a specific Clean List or voluntary certification only demonstrates that a product or ingredient meets the requirements covered by that system. It does not automatically demonstrate compliance with cosmetic regulations in every target market.

In the European Union, cosmetic claims must also meet the common criteria of legal compliance, truthfulness, evidential support, honesty, fairness, and informed decision-making. Using the same term does not mean that every product can rely on the same evidence or wording.

What Evidence Is Required for Clean Beauty Claims?

Different claims require different supporting data. Supplier declarations, specifications, and test reports can only substantiate the specific raw material, batch, method, and version clearly covered by the document. A conclusion about one ingredient cannot be directly extended to the complete finished product.

Evidence Matrix for Common Claims

How Far Can a Raw Material Supplier Substantiate a Claim?

A supplier’s core responsibility in a clean beauty project is to accurately describe what the supplied raw material is, what it contains, how the data were generated, and how downstream users will be notified of product changes.

Finished-product labeling, complete safety conclusions, and final market claims still need to be assessed by the brand, manufacturer, or relevant responsible person based on the complete formulation.

Evidence Responsibilities of Different Parties

Supplier documentation forms part of the finished-product evidence chain, but it is not the complete evidence chain. Unclear responsibility boundaries can create two types of problems: suppliers may be asked to substantiate finished-product conclusions beyond the raw material level, or brands may directly convert raw material statements into product claims without sufficient verification.

What Is the Difference Between “Not Added,” “Not Detected,” and “Free From”?

These three concepts are often used interchangeably in clean beauty labeling, but they represent different levels of evidence and scopes of application.

Why LOD and LOQ Matter

LOD generally refers to the limit of detection, which is the lowest level at which an analytical method can identify the presence of a substance.

LOQ generally refers to the limit of quantification, which is the lowest level at which an analytical method can quantify a substance with acceptable accuracy and precision.

If a regulatory limit, retailer standard, or internal company threshold is lower than the laboratory method’s LOQ, a “not detected” result may still be insufficient to demonstrate that the substance is below the required threshold.

Therefore, “ND” or “not detected” should be reviewed together with:

• Test method;
• LOD or LOQ;
• Sample batch;
• Test matrix;
• Reporting unit;
• Scope of substances tested;
• Report date;
• Applicable product code and version.

A not-detected result only has corresponding decision-making value when the analytical capability is aligned with the relevant assessment threshold.

What Questions Should Supplier Documentation Answer?

A clean beauty project does not require the mechanical collection of large numbers of documents. Useful documentation should answer specific questions and correspond to the actual supplied product, sample, and commercial batch.

Uses of Key Documents and Data

Documents should also use consistent product names, product codes, dates, and versions.

The same trade name with different product codes, or a mismatch between sample documentation and commercial supply specifications, may cause labels and claims to be based on incorrect data.

Typical Values, Specification Ranges, and Single-Batch Results Should Not Be Confused

Data in supplier documentation can generally be divided into three categories:

• Typical value: Describes the usual performance of the product and is not necessarily a release requirement for every batch;
• Specification range: Represents the upper and lower limits or acceptance criteria that the supplier commits to controlling;
• Single-batch result: Represents the actual test data for a particular sample or commercial batch.

Treating a typical value as a guaranteed value, or using one single-batch result to represent long-term supply, can increase the risk of future batch variation and incorrect labeling decisions.

Which Changes Require a New Review of the Claim?

A clean beauty claim does not remain valid indefinitely after a single review. If a factor affecting raw material composition, use concentration, analytical capability, or evidence applicability changes, the original conclusion may need to be reassessed.

Common Triggers for Claim Reassessment

A formal change-notification mechanism can reduce the risk of marketed products continuing to rely on outdated data, invalid declarations, or obsolete labels.

Ingredient Substitution Cannot Focus Only on the Restricted-Ingredient List

Some ingredients excluded by brand standards or Clean Lists may perform essential functions in a formulation, including preservation, emulsification, solubilization, chelation, antioxidation, rheology control, or sensory modification.

Three questions should be answered before substitution:

1. What function does the original ingredient perform in the formulation?
2. Does the alternative ingredient provide a similar mechanism and process window?
3. Which performance parameters, documents, and claims need to be revalidated after substitution?

For example, removing a conventional preservative and adding only a multifunctional ingredient with some antimicrobial activity does not automatically demonstrate that the formulation has sufficient microbiological protection. A complete assessment should also consider product water content, pH, packaging format, production conditions, conditions of use, and preservative efficacy test results.

Similarly, replacing an existing system with a natural emulsifier may still result in reduced viscosity, phase separation during thermal cycling, odor changes, or incompatibility with production-scale shear conditions, even when the ingredient name and brand standard requirements are satisfied.

Ingredient selection should therefore follow a clear causal sequence:

Claim requirement → Ingredient function → Substitution logic → Key parameters → Formulation verification → Labeling and supply risk

Documentation Priorities for Different Raw Material Categories

Documentation requirements for cosmetic ingredients and personal care materials should be determined by raw material complexity, actual function, and the intended claim, rather than applying the same checklist to every product.

The 2026 EU Fragrance Allergen Labeling Milestone

The expanded EU fragrance allergen labeling requirements place more detailed data expectations on fragrances, essential oils, botanical extracts, and other raw materials that may introduce relevant substances.

Individual labeling assessment is required when the concentration of a relevant fragrance allergen in the finished product exceeds:

• Leave-on products: 0.001%;
• Rinse-off products: 0.01%.

More detailed requirements for quantitative allergen data, analytical methods, LOQ, product versions, and change notification are discussed in the 2026 EU cosmetic fragrance allergen labeling guide.Products that do not comply with the new requirements but meet the original transitional conditions may be placed on the EU market until July 31, 2026.

From August 1, 2026, newly placed products on the EU market must comply with the expanded labeling requirements. Products that were lawfully placed on the market earlier and meet the transitional conditions may continue to be made available on the EU market until July 31, 2028.

“Placed on the market” generally refers to the first supply of a product on the EU market, while “made available on the market” concerns the continued supply of a product already placed on the market through the distribution chain. The two dates apply to different supply-chain stages and should not be treated as the same deadline.

The direct impact of this change is not limited to adding more names to the ingredient list. Suppliers need to provide quantitative data that can support finished-product calculations and ensure that the data correspond to the current version of the fragrance, essential oil, or blended raw material.

The Impact of U.S. MoCRA on Documentation Responsibilities

The U.S. Modernization of Cosmetics Regulation Act of 2022 (MoCRA) strengthened the responsibilities of cosmetics companies regarding safety substantiation, serious adverse event reporting, applicable facility registration, and product listing.

Certain small businesses and specific products may qualify for relevant exemptions. Registration and listing requirements therefore need to be assessed based on the company and product circumstances.

Product listing does not constitute FDA approval and cannot be used to support “FDA approved” cosmetic claims. With the exception of applicable color additives, ordinary cosmetics and most cosmetic ingredients in the United States generally do not undergo FDA premarket approval. Companies nevertheless remain responsible for product safety, labeling, and compliance.

These requirements point to a common trend: ingredient names and generic declarations are no longer sufficient to support complex labeling. The responsible person needs to maintain evidence that is clear, reviewable, and capable of being updated over time.

Practical Impact on R&D, Quality, and the Supply Chain

R&D and Formulation

The following information should be recorded during formulation development:

• Actual function of the raw material;
• Intended use concentration;
• Planned product claims;
• Required supplier data;
• Items requiring revalidation after ingredient substitution.

This can prevent a situation in which the formulation is completed before it becomes apparent that the raw material documentation cannot support the planned labeling or retailer requirements.

Quality and Regulatory Affairs

The focus of document review needs to shift from “Has the document been received?” to:

• Does the document correspond to the current product code?
• Is the data a typical value, specification range, or single-batch result?
• Can the test method meet the actual decision threshold?
• Are the applicable market and document version clearly stated?
• Does a raw material change require a new review of the label and claim?

Procurement and Supply Chain

Raw material unit price is not the only cost. A lower-priced ingredient that lacks compositional data, quantitative reports, or change notification may create hidden costs, including:

• Additional testing;
• Repeated sample verification;
• Label rework;
• Delays in retailer review;
• Reconfirmation of commercial batches;
• Formulation or packaging adjustments.

Supply evaluation should therefore consider data availability, continuity between samples and commercial supply, responsiveness to changes, and long-term documentation support.

Three Stages from Documentation Request to Commercial Procurement

The three stages address different questions. Receiving documentation does not mean that a sample has passed verification, and passing sample verification does not mean that commercial batches and future supply can automatically rely on the same conclusion.

How ChemicalCell Supports Raw Material Information Confirmation

ChemicalCell can assist with confirming product identity, specifications, compositional information, and the available scope of documentation for cosmetic ingredients and personal care materials during the inquiry stage.

Relevant support may include:

• Verifying the raw material name, INCI, CAS number, botanical source, or product code;
• Communicating blended composition, carriers, specifications, and application range;
• Confirming the availability of allergen, source, not-added, or restricted-substance information;
• Matching samples, commercial products, and document versions;
• Organizing the data that need to be confirmed with the supplier based on the specific claim.

Finished-product labeling, market claims, and final compliance still need to be assessed based on the complete formulation, actual use concentration, product type, and target-market requirements.

FAQ

Is Clean Beauty a Legally Defined Cosmetics Category?

Clean beauty is currently not a cosmetics category with a globally unified legal definition.

Different retailers, brands, and voluntary certification schemes may establish their own standards, but individual products must still comply with target-market requirements for prohibited and restricted ingredients, safety assessment, labeling, and advertising claims.

Can a Supplier’s “Not Added” Declaration Directly Support a “Free From” Claim?

Usually not.

A “not added” declaration only indicates that the supplier did not intentionally introduce the specified substance. It does not automatically exclude carryover from blended ingredients, natural complex substances, impurities, process residues, or cross-contact. Before using a “free from” statement, the substance scope, evidence basis, and applicable product version need to be clearly defined.

Can One Supplier Declaration Demonstrate That a Finished Product Meets a Natural-Origin or Clean Beauty Standard?

Not on its own.

A supplier declaration only covers a specific raw material, product code, and document version. A finished-product conclusion also needs to consider all formulation components, actual addition ratios, the calculation method required by the target standard, labeling requirements, and any necessary finished-product evidence.

Requirements may also differ among retailers and certification systems. Passing one system does not mean that a product automatically meets another.

Which Raw Material Changes Require a New Review of a Clean Beauty Claim?

Changes in carriers, blend ratios, botanical sources, extraction methods, preservation systems, fragrance composition, upstream suppliers, use concentrations, or analytical methods may affect the original claim.

The need for reassessment depends on whether the change affects the ingredient list, natural-origin percentage, concentration of specific substances, test conclusion, finished-product performance, or scope of evidence applicability.

RFQ Information

The following information may be provided when submitting an inquiry for raw materials related to clean beauty claims:

When confirming whether a cosmetic raw material can support a specific clean beauty claim, the target market, raw material function, intended use concentration, specific claim, and required documentation can be stated when you submit a cosmetic ingredient RFQ.

Key Regulations and Official Regulatory Materials

• Regulation (EC) No 1223/2009 on Cosmetic Products
• Commission Regulation (EU) No 655/2013 on Common Criteria for Cosmetic Claims
• Commission Regulation (EU) 2023/1545 on the Labelling of Fragrance Allergens in Cosmetic Products
• U.S. Food and Drug Administration: Modernization of Cosmetics Regulation Act of 2022 (MoCRA)
• U.S. Food and Drug Administration: FDA Authority Over Cosmetics
• U.S. Food and Drug Administration: Registration and Listing of Cosmetic Product Facilities and Products